Form 4: Aptose Biosciences Inc.: Former Officer's Statement of Changes in Beneficial Ownership
SEC Filing
Philippe Ledru, a former officer of Aptose Biosciences Inc., filed a Form 4 indicating changes in beneficial ownership of the company's securities.
Summary
- A Form 4 filing was submitted to the SEC by Philippe Ledru, a former officer of Aptose Biosciences Inc.
- The filing pertains to changes in the beneficial ownership of Aptose Biosciences Inc. securities.
- The date of the earliest transaction reported is February 23, 2024.
- The form indicates that Ledru is a former officer of the company.
Sentiment
Score: 5
Explanation: This is a standard regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of compliance for insiders of publicly traded companies, providing transparency into their transactions in the company's stock.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 02/23/2024 | Date of earliest transaction |
| 05/10/2024 | Date of signature on the report |
Keywords
Form 4, beneficial ownership, Aptose Biosciences, securities, SEC filing, officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.